Our results obtained by analyzing 162 gastric cancer patients and 125 chronic gastritis and 165 precancerous gastric lesions from three study centers showed that CD44 protein staining was positive in patients with precancerous (21.4%) and gastric cancer (65%) and negative with chronic gastritis. This evidence concerns the gene CD44 and gastric cancer.